Clinically Important Improvements in Asthma-Specific Quality of Life, But No Difference in Conventional Clinical Indexes in Patients Changed From Conventional Beclomethasone Dipropionate to Approximately Half the Dose of Extrafine Beclomethasone Dipropionate
- 1 June 2002
- Vol. 121 (6) , 1824-1832
- https://doi.org/10.1378/chest.121.6.1824
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Long-term safety and efficacy of a chlorofluorocarbon-free beclomethasone dipropionate extrafine aerosolAnnals of Allergy, Asthma & Immunology, 2001
- Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellantJournal of Allergy and Clinical Immunology, 1999
- Asthma quality of life during 1 year of treatment with budesonide with or without formoterolEuropean Respiratory Journal, 1999
- Health-Related Quality of Life in Moderate AsthmaChest, 1999
- Hydrofluoroalkane-134a Beclomethasone Dipropionate, 400 μg, Is as Effective as Chlorofluorocarbon Beclomethasone Dipropionate, 800 μg, for the Treatment of Moderate AsthmaChest, 1999
- New Delivery Systems and PropellantsCanadian Respiratory Journal, 1999
- Quality of life in asthma clinical trials: comparison of salmeterol and salbutamol.American Journal of Respiratory and Critical Care Medicine, 1995
- Determining a minimal important change in a disease-specific quality of life questionnaireJournal of Clinical Epidemiology, 1994
- Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials.Thorax, 1992
- Standardization of Spirometry—1987 UpdateAmerican Review of Respiratory Disease, 1987